Signaling Pathways Involved in Megakaryocyte‐Mediated Proliferation of Osteoblast Lineage Cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cellular Physiology

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.24774PMID 25160801PMCID PMC4433553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pyk2 regulates megakaryocyte‐induced increases in osteoblast number and bone formation

  2013cited by this paper
• Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.

  2013cited by this paper
• Megakaryocytes Regulate Expression of Pyk2 Isoforms and Caspase-mediated Cleavage of Actin in Osteoblasts*

  2012cited by this paper
• Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation

  2010cited by this paper
• Involvement of integrins α3β1 and α5β1 and glycoprotein IIb in megakaryocyte‐induced osteoblast proliferation

  2010cited by this paper
• Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

  2009cited by this paper
• MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle

  2009cited by this paper
• The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation.

  2009cited by this paper
• The Retinoblastoma Protein Tumor Suppressor Is Important for Appropriate Osteoblast Differentiation and Bone Development

  2008cited by this paper
• Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease.

  2008cited by this paper
• Targeting Retinoblastoma Protein for Degradation by Proteasomes

  2006cited by this paper
• Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling

  2006cited by this paper
• Hdm2 Nuclear Export, Regulated by Insulin-like Growth Factor-I/MAPK/p90Rsk Signaling, Mediates the Transformation of Human Cells*

  2006cited by this paper
• Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.

  2006cited by this paper
• Megakaryocyte-mediated inhibition of osteoclast development.

  2006cited by this paper
• Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype.

  2005cited by this paper
• MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

  2005cited by this paper
• HDM2 phosphorylation by MAPKAP kinase 2

  2005cited by this paper
• The Central Acidic Domain of MDM2 Is Critical in Inhibition of Retinoblastoma-mediated Suppression of E2F and Cell Growth*

  2004cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.

  2004cited by this paper
• Megakaryocyte–Bone Marrow Stromal Cell Aggregates Demonstrate Increased Colony Formation and Alkaline Phosphatase Expression in Vitro

  2004cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003influential reference
• Megakaryocyte‐Osteoblast Interaction Revealed in Mice Deficient in Transcription Factors GATA‐1 and NF‐E2

  2003cited by this paper
• Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

  2003cited by this paper
• Transcription: Sibling rivalry in the E2F family

  2002cited by this paper
• Use of Cultured Osteoblastic Cells to Identify and Characterize Transcriptional Regulatory Complexes

  2002cited by this paper
• A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

  2001cited by this paper
• The MDM2 RING-finger domain is required to promote p53 nuclear export

  2000cited by this paper
• Cell cycle control and cancer.

  2000cited by this paper
• Human mesenchymal stem cells support megakaryocyte and pro‐platelet formation from CD34+ hematopoietic progenitor cells

  2000cited by this paper
• Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders – aids to diagnosis and classification

  1999cited by this paper
• RB regulates the stability and the apoptotic function of p53 via MDM2.

  1999cited by this paper
• Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.

  1998cited by this paper
• [Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis].

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• The MDM2 C-terminal Region Binds to TAFII250 and Is Required for MDM2 Regulation of the Cyclin A Promoter*

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice.

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development

  1997cited by this paper
• Thrombopoietin signal transduction in purified murine megakaryocytes.

  1997cited by this paper
• Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

  1997cited by this paper
• [MASS phenotype].

  1996cited by this paper
• A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.

  1996cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Interaction between the retinoblastoma protein and the oncoprotein MDM2

  1995cited by this paper
• Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice.

  1995cited by this paper
• Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.

  1995cited by this paper
• Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.

  1995cited by this paper
• Regulation of Transcription Functions of the p53 Tumor Suppressor by the mdm-2 Oncogene

  1995cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Expression and regulation of Ly-6 differentiation antigens by murine osteoblasts.

  1994cited by this paper
• Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein.

  1993cited by this paper
• Retinoblastoma protein and the cell cycle.

  1993cited by this paper
• Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

  1992cited by this paper
• Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR- bone marrow cells.

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Abrogation by c-myc of Gl phase arrest induced by RB protein but not by p53

  1992cited by this paper
• Abrogation by c-myc of Gl phase arrest induced by RB protein but not by p53

  1992cited by this paper
• The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

  1991cited by this paper
• The E2F transcription factor is a cellular target for the RB protein.

  1991cited by this paper
• Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone

  1991cited by this paper
• p53 functions as a cell cycle control protein in osteosarcomas

  1990cited by this paper
• Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

  1990cited by this paper
• Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

  1988cited by this paper
• Formation of bone by isolated, cultured osteoblasts in millipore diffusion chambers

  1982cited by this paper
• Role of phosphodiesterase in the parathormone-stimulated adenosine 3',5'-monophosphate response in bone cell populations enriched in osteoclasts and osteoblasts.

  1981cited by this paper
• Patho-anatomical features of the bone marrow.

  1975cited by this paper
• Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces.

  1975influential reference

• Cxcr2 is Required for Osteoclast Regulation, Bone Structure, and Hematological Response During Bone (Re)modeling

  2026cites this paper
• The effects of young and aged, male and female megakaryocyte conditioned media on angiogenic properties of endothelial cells

  2024cites this paper
• Analysis of the effects of spaceflight and local administration of thrombopoietin to a femoral defect injury on distal skeletal sites

  2021cites this paper
• Analysis of the effects of spaceflight and local administration of thrombopoietin to a femoral defect injury on distal skeletal sites

  2021cites this paper
• Megakaryocyte-driven changes in bone health: lessons from mouse models of myelofibrosis and related disorders.

  2021cites this paper
• Myeloproliferative Disorders and its Effect on Bone Homeostasis: The Role of Megakaryocytes.

  2021cites this paper
• Effects of mechanobiological signaling in bone marrow on skeletal health

  2020cites this paper
• Megakaryocytes promote osteoclastogenesis in aging

  2020cites this paper
• Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass.

  2019cites this paper
• The high bone mass phenotype of Lrp5-mutant mice is not affected by megakaryocyte depletion.

  2018cites this paper
• Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis

  2018cites this paper
• BMP-2 indirectly induces angiogenesis during large bone defect regeneration

  2017cites this paper
• Lnk Deficiency Leads to TPO‐Mediated Osteoclastogenesis and Increased Bone Mass Phenotype

  2017cites this paper
• Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms

  2016cites this paper
• The role of platelets and megakaryocytes in bone metastasis

  2016cites this paper
• C‐Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis

  2016cites this paper
• The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control

  2015cites this paper
• Stem Cell Niche-Radiobiological Response

  2015cites this paper